Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Accelerated apoptosis in the Timp-3–deficient mammary gland
Jimmie E. Fata, … , Roger A. Moorehead, Rama Khokha
Jimmie E. Fata, … , Roger A. Moorehead, Rama Khokha
Published September 15, 2001
Citation Information: J Clin Invest. 2001;108(6):831-841. https://doi.org/10.1172/JCI13171.
View: Text | PDF | Corrigendum
Article

Accelerated apoptosis in the Timp-3–deficient mammary gland

  • Text
  • PDF
Abstract

The proapoptotic proteinase inhibitor TIMP-3 is the only molecule of this family thought to influence cell death. We examined epithelial apoptosis in TIMP-3–deficient mice during mammary gland involution. Lactation was not affected by the absence of TIMP-3, but glandular function, as measured by gland-to-body weight ratio and production of β-casein, was suppressed earlier during post-lactational involution than in controls. Histological examination revealed accelerated lumen collapse, alveolar-epithelial loss, and adipose reconstitution in Timp-3–/– females. Epithelial apoptosis peaked on the first day of involution in Timp-3–null glands but at day 3 in wild-type littermates. Unscheduled activation of gelatinase-A was evident by zymography and correlated with earlier fragmentation of fibronectin in Timp-3–/– mammary. To obtain independent evidence of the proapoptotic effects of TIMP-3 deficiency, we introduced recombinant TIMP-3–releasing pellets into regressing Timp-3–/– mammary tissue and showed that this treatment rescued lumen collapse and epithelial apoptosis. Ex vivo, involuting Timp-3–/– mammary tissue demonstrated accelerated epithelial apoptosis that could be reduced by metalloproteinase inhibition. The physiological relevance of TIMP-3 became apparent as Timp-3–/– dams failed to reestablish lactation after brief cessation of suckling. Thus, TIMP-3 is a critical epithelial survival factor during mammary gland involution.

Authors

Jimmie E. Fata, Kevin J. Leco, Evelyn B. Voura, Hoi-Ying E. Yu, Paul Waterhouse, Gillian Murphy, Roger A. Moorehead, Rama Khokha

×

Total citations by year

Year: 2022 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Total
Citations: 2 1 2 3 3 1 2 3 3 3 5 4 5 5 3 1 3 4 7 2 62
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (62)

Title and authors Publication Year
Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding
Spanò DP, Scilabra SD
Membranes 2022
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma.
Mazzoni M, Todoerti K, Agnelli L, Minna E, Pagliardini S, Di Marco T, Borrello MG, Neri A, Greco A
Cancer Cell International 2022
Cardiac Chagas Disease: MMPs, TIMPs, Galectins, and TGF- β as Tissue Remodelling Players
AW da Costa, JR do Carmo Neto, YL Braga, BA Silva, AB Lamounier, BO Silva, MA dos Reis, FA de Oliveira, MR Celes, JR Machado
Disease Markers 2019
TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production
X Han, H Mo, X Liu, Y Li, L Du, H Qiao, Q Fan, J Zhao, S Zhang, T Tang
Frontiers in Genetics 2018
Sorsby fundus dystrophy: Insights from the past and looking to the future
B Anand-Apte, JR Chao, R Singh, H Stöhr
Journal of Neuroscience Research 2018
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy
R Rodriguez-Barrueco, EA Nekritz, F Bertucci, J Yu, F Sanchez-Garcia, TZ Zeleke, A Gorbatenko, D Birnbaum, E Ezhkova, C Cordon-Cardo, P Finetti, D Llobet-Navas, JM Silva
Genes & development 2017
Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J, Khalil RA
Progress in molecular biology and translational science 2017
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
Wang X, Khalil RA
Advances in pharmacology (San Diego, Calif.) 2017
Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity
CM Doherty, R Visse, D Dinakarpandian, DK Strickland, H Nagase, L Troeberg
The Journal of biological chemistry 2016
TIMPs: versatile extracellular regulators in cancer
HW Jackson, V Defamie, P Waterhouse, R Khokha
Nature Reviews Cancer 2016
Epigenetic modification suppresses proliferation, migration and invasion of urothelial cancer cell lines
P Brockmeyer, B Hemmerlein
Oncology Letters 2016
Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism
JH Qi, B Anand-Apte
Apoptosis 2015
Sulfated Glycosaminoglycans Control the Extracellular Trafficking and the Activity of the Metalloprotease Inhibitor TIMP-3
L Troeberg, C Lazenbatt, MF Anower-E-Khuda, C Freeman, O Federov, H Habuchi, O Habuchi, K Kimata, H Nagase
Chemistry & Biology 2014
Is there new hope for therapeutic matrix metalloproteinase inhibition?
RE Vandenbroucke, C Libert
Nature Reviews Drug Discovery 2014
Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome
SA Syggelos, AJ Aletras, I Smirlaki, SS Skandalis
BioMed Research International 2013
The Significance of Matrix Metalloproteinases in Parasitic Infections Involving the Central Nervous System
F Bruschi, B Pinto
Pathogens 2013
Cell Surface-Bound TIMP3 Induces Apoptosis in Mesenchymal Cal78 Cells through Ligand-Independent Activation of Death Receptor Signaling and Blockade of Survival Pathways
C Koers-Wunrau, C Wehmeyer, A Hillmann, T Pap, B Dankbar, AL Gartel
PloS one 2013
Matrix Metalloproteinase Inhibitors
SP Gupta
2012
Mammary gland development
H Macias, L Hinck
Wiley Interdisciplinary Reviews Developmental Biology 2012
Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1
SD Scilabra, L Troeberg, K Yamamoto, H Emonard, I Thøgersen, JJ Enghild, DK Strickland, H Nagase
The Journal of biological chemistry 2012
TIMP3 Regulates Mammary Epithelial Apoptosis with Immune Cell Recruitment Through Differential TNF Dependence
CV Hojilla, HW Jackson, R Khokha
PloS one 2011
Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3
T Neill, H Painter, S Buraschi, RT Owens, MP Lisanti, L Schaefer, RV Iozzo
The Journal of biological chemistry 2011
Tissue inhibitors of metalloproteinases
G Murphy
Genome biology 2011
Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload
I Koskivirta, Z Kassiri, O Rahkonen, R Kiviranta, GY Oudit, TD McKee, V Kytö, A Saraste, E Jokinen, PP Liu, E Vuorio, R Khokha
The Journal of biological chemistry 2010
Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury
SE Gill, I Huizar, EM Bench, SW Sussman, Y Wang, R Khokha, WC Parks
The American Journal of Pathology 2010
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
K Brew, H Nagase
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2010
Mammary gland reprogramming: metalloproteinases couple form with function
R Khokha, Z Werb
Cold Spring Harbor perspectives in biology 2010
Down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) expression is necessary for adipocyte differentiation
D Bernot, E Barruet, M Poggi, B Bonardo, MC Alessi, F Peiretti
The Journal of biological chemistry 2010
S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis
JH Qi, G Dai, P Luthert, S Chaurasia, J Hollyfield, BH Weber, H Stöhr, B Anand-Apte
The Journal of biological chemistry 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Mammary involution and breast cancer risk: transgenic models and clinical studies
DC Radisky, LC Hartmann
Journal of Mammary Gland Biology and Neoplasia 2009
Differentiation of the Mammary Epithelial Cell during Involution: Implications for Breast Cancer
J Monks, PM Henson
Journal of Mammary Gland Biology and Neoplasia 2009
Progress in matrix metalloproteinase research
G Murphy, H Nagase
Molecular Aspects of Medicine 2008
Low Tissue Inhibitor of Metalloproteinases 3 and High Matrix Metalloproteinase 14 Levels Defines a Subpopulation of Highly Invasive Foam-Cell Macrophages
JL Johnson, GB Sala-Newby, Y Ismail, CM Aguilera, AC Newby
Arteriosclerosis, thrombosis, and vascular biology 2008
Inflammation and breast cancer: metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer
CV Hojilla, GA Wood, R Khokha
Breast Cancer Research 2008
Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities
WG Stetler-Stevenson
Science signaling 2008
The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2
WG Stetler-Stevenson
Cancer metastasis reviews 2008
Matrix metalloproteinases and the regulation of tissue remodelling
A Page-McCaw, AJ Ewald, Z Werb
Nature reviews. Molecular cell biology 2007
The Molecular Culprits Underlying Precocious Mammary Gland Involution
KD Sutherland, GJ Lindeman, JE Visvader
Journal of Mammary Gland Biology and Neoplasia 2007
Extracellular proteolysis in transgenic mouse models of breast cancer
K Almholt, KA Green, A Juncker-Jensen, BS Nielsen, LR Lund, J Rømer
Journal of Mammary Gland Biology and Neoplasia 2007
Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk
Y Wan, A Saghatelian, LW Chong, CL Zhang, BF Cravatt, RM Evans
Genes & development 2007
Immunohistochemical changes in vulnerable rat brain regions after reversible global brain ischaemia
G Martinez, G Musumeci, C Loreto, ML Carnazza
Journal Of Molecular Histology 2007
c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3
KD Sutherland, F Vaillant, WS Alexander, TM Wintermantel, NC Forrest, SL Holroyd, EJ McManus, G Schutz, CJ Watson, LA Chodosh, GJ Lindeman, JE Visvader
The EMBO Journal 2006
Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein
KK Jung, XW Liu, R Chirco, R Fridman, HR Kim
The EMBO Journal 2006
Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ
CJ Watson
Breast Cancer Research 2006
Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis.
Mahmoodi M, Sahebjam S, Smookler D, Khokha R, Mort JS
The American Journal of Pathology 2005
Apoptosis regulation in the mammary gland
KA Green, CH Streuli
Cellular and Molecular Life Sciences 2004
Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression
SL White, S Gharbi, MF Bertani, HL Chan, MD Waterfield, JF Timms
British Journal of Cancer 2004
Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3
T Yokoyama, H Nakamura, Y Otani, T Kubota, N Fujimoto, M Seiki, M Kitajima, Y Okada
Clinical & Experimental Metastasis 2004
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis
D Fukumura, A Ushiyama, DG Duda, L Xu, J Tam, V Krishna, K Chatterjee, I Garkavtsev, RK Jain
Circulation research 2003
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution
S Schenk, E Hintermann, M Bilban, N Koshikawa, C Hojilla, R Khokha, V Quaranta
The Journal of Cell Biology 2003
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development
CV Hojilla, FF Mohammed, R Khokha
British Journal of Cancer 2003
Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes
JE Fata, Z Werb, MJ Bissell
Breast Cancer Research 2003
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells
M Osman, M Tortorella, M Londei, S Quaratino
Immunology 2002
Do inflammatory cells participate in mammary gland involution?
Jenifer Monks, F Jon Geske, Lisa Lehman, Valerie A Fadok
Journal of Mammary Gland Biology and Neoplasia 2002
Maspin is a tumour suppressor that inhibits breast cancer tumour metastasis in vivo
CH Streuli
Breast Cancer Research 2002
Regulation of BRCA1 expression and its relationship to sporadic breast cancer
CR Mueller, CD Roskelley
Breast Cancer Research 2002
Stromal Effects on Mammary Gland Development and Breast Cancer
BS Wiseman, Z Werb
Science 2002
Metalloproteases and adipogenesis: a weighty subject.
Lilla J, Stickens D, Werb Z
The American Journal of Pathology 2002
Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function.
Marshman E, Streuli CH
Breast Cancer Research 2002
Spontaneous air space enlargement in the lungs of tissue inhibitor of metalloproteinases-3 (TIMP-3) deficient mice
Kevin J. Leco, Paul Waterhouse, Otto H. Sanchez, Katrina L. M. Gowing, A. Robin Poole, Andrew Wakeham, Tak W. Mak, Rama Khokha
Journal of Clinical Investigation 2001
That impish TIMP: the tissue inhibitor of metalloproteinases 3
Frederick J. Woessner
Journal of Clinical Investigation 2001

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts